<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03302208</url>
  </required_header>
  <id_info>
    <org_study_id>UTF-9</org_study_id>
    <nct_id>NCT03302208</nct_id>
  </id_info>
  <brief_title>Preoperative Oral Pregabalin Effect on Inhalational Anesthetic Requirements ln Hysterectomy Under General Anesthesia</brief_title>
  <official_title>Role of Preoperative Oral Pregabalin in Reducing Inhalational Anesthetic Requirements in Elective Abdominal Hysterectomy Under General Anesthesia: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nesrine El-Refai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators hypothesized that preoperative pregabalin tablet (150 mg
      orally ) may be effective in reducing intraoperative isoflurane requirements needed to
      maintain intraoperative hemodynamics within ± 20% of baseline measurement and/or attenuates
      hemodynamic response to endotracheal intubation in female patients ASA I or II , aged 18-60
      years, schedule for elective abdominal hysterectomy surgery under general anesthesia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the investigators hypothesized that preoperative pregabalin tablet (150 mg
      orally ) would be effective in reducing intraoperative isoflurane requirement needed to
      maintain intraoperative hemodynamics within ± 20% of baseline measurement and/or attenuates
      hemodynamic response to endotracheal intubation in female patients ASA I or II schedule for
      elective abdominal hysterectomy surgery under general anaesthesia.

      The investigators aim to compare the efficacy of preoperative oral pregabalin versus placebo
      in reducing intraoperative isoflurane requirements needed to maintain intraoperative
      hemodynamic stability (Blood pressure and heart rate within ± 20% of baseline measurements)
      in female patients ASA I/II undergoing elective abdominal hysterectomy surgery under general
      anaesthesia.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 29, 2017</start_date>
  <completion_date type="Actual">September 20, 2017</completion_date>
  <primary_completion_date type="Actual">September 1, 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Inhalational anaesthetic drug requirements</measure>
    <time_frame>an average of 3 hours after induction</time_frame>
    <description>Inhalational anaesthetic requirements to maintain hemodynamic stability (± 20% of the baseline) using MAQUET Flow-I anesthetic machine.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pressor response attenuation</measure>
    <time_frame>an average of 10 minutes after induction</time_frame>
    <description>Degree of pressor response attenuation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>First time for analgesics requirement</measure>
    <time_frame>postoperative (maximum 6 hours after the end of operation)</time_frame>
    <description>First time for analgesics requirement.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>pregabalin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Pregabalin capsule 150 mg oral</description>
    <arm_group_label>pregabalin group</arm_group_label>
    <other_name>laryca</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female patients, aged 18-60 year scheduled for elective abdominal hysterectomy surgery
             under general anaesthesia.

          -  American Society of Anaesthesiology (ASA) physical status I or II.

        Exclusion Criteria:

          -  American Society of Anaesthesiology (ASA) physical status ≥ III.

          -  Allergy or hypersensitivity to pregabalin.

          -  Patient on calcium channel blocker or anticonvulsant.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <state>Zamalek</state>
        <zip>11586</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2017</study_first_submitted>
  <study_first_submitted_qc>October 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2017</study_first_posted>
  <last_update_submitted>January 7, 2018</last_update_submitted>
  <last_update_submitted_qc>January 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nesrine El-Refai</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>General Anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Anesthetics, Inhalation</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

